Key result
Concurrent Cox-Maze IV ablation in elderly patients undergoing high-risk cardiac surgery was associated with lower 30-day mortality and 80.0% sinus rhythm at latest follow-up.
Why the study?
To evaluate the outcomes of concurrent Cox-Maze procedures in elderly patients undergoing high-risk cardiac surgery.
Does concurrent Cox-Maze IV AF ablation improve long-term survival and sinus rhythm maintenance in elderly patients with AF undergoing high-risk cardiac surgery?
Cohort (n=239)
Does concurrent Cox-Maze IV AF ablation improve long-term survival and sinus rhythm maintenance in elderly patients with AF undergoing high-risk cardiac surgery?
Concomitant Cox-Maze IV ablation during high-risk cardiac surgery in elderly patients is associated with improved long-term survival, better maintenance of sinus rhythm, and improved NYHA functional status without increasing surgical risk.
Answers are grounded in this paper and cite their sources.
May support ablation consideration in select elderly high-risk surgery; leaves open causal benefit pending randomized confirmation.
BACKGROUND/AIM To evaluate outcomes of concurrent Cox-Maze procedures in elderly patients undergoing high-risk cardiac surgery. MEHODS We retrospectively identified patients aged over 70 years with Atrial Fibrillation (AF) from 2011 to 2017 who had two or more other cardiac procedures. They were subdivided into two groups: 1. Cox-Maze IV AF ablation 2. No-Surgical AF treatment. Patients requiring redo procedures or those who had isolated PVI or LAAO were excluded. Heart rhythm assessed from Holter reports or 12-lead ECG. Follow-up data collected through telephone consultations and medical records. RESULTS There were 239 patients. Median follow up was 61 months. 70 patients had Cox-Maze IV procedures (29.3%). Demographic, intra- and post-operative outcomes were similar between groups although duration of pre-operative AF was shorter in Cox-Maze group (p=0.001). One (1.4%) patient in Cox maze group with 30-day mortality compared to 14 (8.2%) the control group (p=0.05). Sinus rhythm at annual and latest follow-up was 84.9% and 80.0% respectively in Maze group - significantly better than No-Surgical AF treatment groups (P<0.001). 160 patients (66.9%) were alive at long-term follow-up with better survival curves in Cox Maze group compared to No-Surgical treatment group (p=0.02). There was significantly higher proportion of patients in NYHA 1 status in Cox-Maze group (p=0.009). No differences observed in freedom from stroke (p=0.80) or permanent pacemaker (p=0.33). CONCLUSIONS. Surgical ablation is beneficial in elderly patients undergoing high-risk surgery - promoting excellent long-term freedom from AF and symptomatic/prognostic benefits. Therefore, surgical risk need not be reason to deny benefits of concomitant AF-ablation.
No takes yet. Share an insight, caveat, or question.
Uzzaman et al. (2021) conducted a cohort in Atrial Fibrillation (AF) in elderly patients undergoing high-risk cardiac surgery (n=239). Cox-Maze IV AF ablation vs. No-Surgical AF treatment was evaluated on 30-day mortality (p=0.05). Concurrent Cox-Maze IV ablation in elderly patients undergoing high-risk cardiac surgery was associated with lower 30-day mortality and 80.0% sinus rhythm at latest follow-up.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: